As of 2024-12-15, the EV/EBITDA ratio of Bristol-Myers Squibb Co (BMY) is 7.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Bmy's latest enterprise value is 154,993.88 mil USD. Bmy's TTM EBITDA according to its financial statements is 21,113.00 mil USD. Dividing these 2 quantities gives us the above Bmy EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 10.0x | 8.7x |
| Forward P/E multiples | 19.0x - 26.1x | 20.4x |
| Fair Price | 59.72 - 121.56 | 80.16 |
| Upside | 7.1% - 117.9% | 43.7% |
| Date | EV/EBITDA |
| 2024-12-13 | 7.34 |
| 2024-12-12 | 7.39 |
| 2024-12-11 | 7.42 |
| 2024-12-10 | 7.57 |
| 2024-12-09 | 7.62 |
| 2024-12-06 | 7.69 |
| 2024-12-05 | 7.64 |
| 2024-12-04 | 7.59 |
| 2024-12-03 | 7.62 |
| 2024-12-02 | 7.74 |
| 2024-11-29 | 7.67 |
| 2024-11-27 | 7.68 |
| 2024-11-26 | 7.63 |
| 2024-11-25 | 7.63 |
| 2024-11-22 | 7.64 |
| 2024-11-21 | 7.58 |
| 2024-11-20 | 7.54 |
| 2024-11-19 | 7.58 |
| 2024-11-18 | 7.44 |
| 2024-11-15 | 7.38 |
| 2024-11-14 | 7.60 |
| 2024-11-13 | 7.59 |
| 2024-11-12 | 7.65 |
| 2024-11-11 | 7.73 |
| 2024-11-08 | 7.18 |
| 2024-11-07 | 7.24 |
| 2024-11-06 | 7.29 |
| 2024-11-05 | 7.36 |
| 2024-11-04 | 7.31 |
| 2024-11-01 | 7.20 |
| 2024-10-31 | 7.34 |
| 2024-10-30 | 7.04 |
| 2024-10-29 | 7.03 |
| 2024-10-28 | 7.04 |
| 2024-10-25 | 6.97 |
| 2024-10-24 | 7.07 |
| 2024-10-23 | 7.08 |
| 2024-10-22 | 7.05 |
| 2024-10-21 | 6.99 |
| 2024-10-18 | 7.10 |
| 2024-10-17 | 7.09 |
| 2024-10-16 | 7.11 |
| 2024-10-15 | 7.05 |
| 2024-10-14 | 7.04 |
| 2024-10-11 | 7.00 |
| 2024-10-10 | 7.02 |
| 2024-10-09 | 7.05 |
| 2024-10-08 | 7.02 |
| 2024-10-07 | 7.12 |
| 2024-10-04 | 7.17 |